TGFβ1-treated fibroblasts can secrete osteopontin (Corallo et al. 2014), an RGD-containing integrin ligand implicated in the promotion of tumour growth, EMT and metastasis (Platzer et al. 2011; Kothari et al. 2016). The gene discussed is TGFB1; the disease is neoplasm.